Safety, Tolerability, and PK of AH-008 Following Single Ascending Dose in Healthy Subjects
Abroad (travel likely)RecruitingPHASE1
Conditions
Chemotherapy-induced Peripheral Neuropathy (CIPN)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
ICON Clinial Research Unit, Salt Lake City, Utah, United States